As per the report by Fortune Business Insights, the global Dermatophytic Onychomycosis Treatment Market size is projected to reach USD 8.64 billion in 2030, at a CAGR of 8.0% during the forecast period, 2023-2030
Dermatophytic Onychomycosis Treatment Market
Pune, India, Sept. 27, 2023 (GLOBE NEWSWIRE) — According to Fortune Business Insights, the global Dermatophytic Onychomycosis Treatment Market Size was valued at USD 4.68 billion in 2022 and is projected to grow from USD 5.05 billion in 2023 to USD 8.64 billion by 2030, exhibiting a CAGR of 8.0% during the forecast period. The expansion can be credited to the growing geriatric population. Various research studies cite that the prevalence of this condition increases with age. This information is provided by Fortune Business Insights™ in its research report titled Dermatophytic Onychomycosis Treatment Market, 2023-2030.
Key Industry Development-
March 2021: HUYABIO International in collaboration with Tianjin Institute of Pharmaceutical Research submitted a Chinese New Drug Application for Efinaconazole as Jublia for treating onychomycosis.
Key Takeaways –
- Dermatophytic Onychomycosis Treatment Market size in North America was USD 2.07 billion in 2022
- Increasing Incidence of Dermatophytic Onychomycosis Expected to Propel Market Expansion
- The Existence of Promising Pipeline Candidates to Stimulate Market Expansion
- The nail paints segment is expected to hold a major market share during the projected period.
Discover the Leading Players Featured in the Report-
- Pfizer Inc. (U.S.)
- Galderma (Switzerland)
- GlaxoSmithKline plc (U.K.)
- Janssen Pharmaceuticals, Inc. (U.S.)
- Cipla Inc. (India)
- Kaken Pharmaceuticals Co., Ltd. (Japan)
Report Scope & Segmentation:
|Forecast Period||2023 to 2030|
|Forecast Period 2023 to 2030 CAGR||8.0%|
|2030 Value Projection||USD 8.64 Billion|
|Dermatophytic Onychomycosis Treatment Market Size in 2022||USD 4.68 Billion|
|Historical Data for||2019 to 2021|
|No. of Pages||136|
|Segments Covered||Product Type, By Route of Administration, Type, Distribution Channel and Geography|
Browse Complete Report Details- https://www.fortunebusinessinsights.com/dermatophytic-onychomycosis-treatment-market-103310
Drivers & Restraints:
Rising Prevalence of Dermatophytic Onychomycosis to Drive the Market Growth
One of the major factors driving the dermatophytic onychomycosis treatment market growth is the growing occurrence of onychomycosis. When compared to that of fingernails, the toenail onychomycosis infection is more common.
Despite such growth opportunities, the unawareness among patients about the seriousness of the infection may hinder the market growth.
By Product Type
- Nail Paints
By Route of Administration
- Over-the-Counter (OTC)
By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Channels
North America to Dominate Owing to Growing Number of Prescriptions for Onychomycosis
The North America dermatophytic onychomycosis treatment market share is projected to witness significant growth over the forecast period. The regional expansion can be credited to the surging number of prescriptions for onychomycosis. As per Moberg Pharma AB’s press release, around 5 million prescriptions are written for onychomycosis treatment every year in the region.
The Asia Pacific market for dermatophytic onychomycosis treatment is expected to expand significantly during the forecast period. The growing prevalence of diabetes has increased the need for dermatophytic onychomycosis treatment in the region, fueling market expansion.
Quick Buy – Dermatophytic Onychomycosis Treatment Market Research Report: https://www.fortunebusinessinsights.com/checkout-page/103310
Prominent Companies Invest in Product Innovations to Outperform the Competitors
Top players of dermatophytic onychomycosis treatment are investing substantial amounts in R&D for the development of innovative products. Some other competitive strategies deployed by companies include mergers and acquisitions, joint ventures, partnerships, and others.
How big is the Dermatophytic Onychomycosis Treatment Market?
Dermatophytic Onychomycosis Treatment Market size was USD 4.68 billion in 2022. It is expected to reach USD 8.64 billion in 2030.
How fast is the Dermatophytic Onychomycosis Treatment Market growing?
The Dermatophytic Onychomycosis Treatment Market will exhibit a CAGR of 8.0% during the forecast period, 2023-2030.
Dermatology Drugs Market Size, Share, Revenue Forecast and Opportunities
Global Anti Fungal Drugs Market Overview, Industry Share and Forecast
Skincare Market Trends, Growth and Global Forecast Report
Medical Aesthetics Market Size, Share, Opportunities & Analysis
Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Fortune Business Insights™ Pvt. Ltd.
US: +1 424 253 0390
UK: +44 2071 939123
APAC: +91 744 740 1245
nDatalyze Corp. (“NDAT” or the “Corporation”) (CSE:NDAT) (OTC:NDATF) Announces an Expansion of its YMI Validation Project
Calgary, Alberta – TheNewswire – October 17, 2023 – nDatalyze Corp. (“NDAT” or the “Corporation”) (CSE:NDAT) (OTC:NDATF) announces an expansion…
Telo Genomics Announces Clinical Launch of Non-Invasive Cancer Diagnostic, TeloViewSMM – An Important Commercial Milestone Achieved
TeloView Analyses Telomeres to Accurately Predict and Characterize Multiple MyelomaToronto, Ontario–(Newsfile Corp. – October 17, 2023) – Telo Genomics…
NervGen Pharma Appoints John Ruffolo to Board of Directors
Extensive experience in private equity, venture capital and advising high growth, innovative companiesBrings personal experience and knowledge of spinal…